Cannabinoids, immune system and cytokine network.

@article{Massi2006CannabinoidsIS,
  title={Cannabinoids, immune system and cytokine network.},
  author={Paola Massi and Angelo Vaccani and Daniela Parolaro},
  journal={Current pharmaceutical design},
  year={2006},
  volume={12 24},
  pages={
          3135-46
        }
}
How cannabinoids influence immune function has been examined extensively in the last 30 years. Studies on drug-abusing humans and animals, as well as in vitro models employing immune cell cultures, have shown that marijuana, natural and endogenous cannabinoid compounds are immunomodulators. These substances modulate host resistance to bacterial, protozoan and viral infections as well as they can profoundly affect the Th1/Th2 response. Recently, two types of cannabinoid receptor, CB1 and CB2… Expand
Cannabinoids and the immune system: an overview.
TLDR
The immune influence of cannabinoid ligands is not fully elucidated, however, aspects of their immunomodulatory effects provide the basis for a context-dependent targeted therapeutic approach, thus leading to the possibility for the use of cannabinoids in the treatment of inflammatory disease. Expand
The endocannabinoid system: a revolving plate in neuro-immune interaction in health and disease
TLDR
Current information on immune effects of cannabinoids in health and disease is outlined and it is shown that the endocannabinoid system represents a revolving plate of neural and immune interactions. Expand
The role of cannabinoids in inflammatory modulation of allergic respiratory disorders, inflammatory pain and ischemic stroke.
This review is intended to offer updated information on the involvement of cannabinoids in the process of inflammation, focusing on immune/allergic reactions, inflammatory pain and neuroinflammationExpand
The Role of the Endogenous Cannabinoid System in Peripheral Analgesia
TLDR
The main goal of this review is to explain the different interactions regarding the cannabinoid system with other cellular components of its environment, its involvement in the modulation of pain at the peripheral level and, more precisely, in different layers of the skin. Expand
Cannabinoids and experimental models of multiple sclerosis.
TLDR
Continued studies of cannabinoid actions in EAE pathogenesis should be beneficial for the better understanding of the mechanisms governing such a vast array of physiological effects and in development of new therapeutic strategies for the treatment of human neuroinflammatory and neurodegenerative diseases. Expand
Cannabinoids as potential new therapeutics of gastrointestinal motility and inflammatory disorders
TLDR
Two studies show that cannabinoid-mediated inhibition of guinea-pig ileum contractions is not mediated through the CB1, CB2, CBe or GPR55 receptor, and the approach of attaching a dendrimer to JWH007 to prevent central nervous system penetration does not appear to be a feasible approach. Expand
Microglia activation states and cannabinoid system: Therapeutic implications.
TLDR
Recent studies that provide new insights into the role of CBs and their endogenous counterparts in defining the profile of microglial activation make CBs a promising therapeutic tool to avoid the detrimental effects of inflammation and possibly paving the way to target microglia in order to generate a reparative milieu in neurodegenerative diseases. Expand
Cannabinoids – Influence on the Immune System and Their Potencial Use in Supplementary Therapy of HIV/AIDS
TLDR
Main constituents of Cannabis sativa were discovered in 1960’s and named after the plant – cannabinoids, and a broad role of endocannabinoids and cannabinoid receptors in a variety of physiological processes as neuromodulation, pain and appetite sensation, motor learning is revealed. Expand
Novel cannabinoid receptors
  • A J Brown
  • Biology, Medicine
  • British journal of pharmacology
  • 2007
TLDR
An introduction to non‐CB1/CB2 pharmacology is presented, information on GPR55 and GPR119 currently available is summarized, and their phylogenetic origin is considered, to consider what aspects of non‐ CB1/ CB2 Pharmacology, if any, they help explain. Expand
Cannabinoids, Inner Ear, Hearing, and Tinnitus: A Neuroimmunological Perspective
TLDR
This review will focus on neuroimmunological mechanisms for cannabinoid effects and their possible use as protective and therapeutic agents in the ear and auditory system, especially in tinnitus. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 109 REFERENCES
Cannabinoid receptors and the regulation of immune response.
  • E. Berdyshev
  • Chemistry, Medicine
  • Chemistry and physics of lipids
  • 2000
TLDR
The functional properties of cannabinoid receptors, signalling pathways linked to cannabinoid receptors and the modulation of immune response by cannabinoid receptor ligands are discussed and special attention is given to 'endocannabinoids' as immunomodulatory molecules. Expand
Endocannabinoids in the immune system and cancer.
TLDR
Further investigations are needed to elucidate the function of endocannabinoids as immunosuppressant and antiproliferative/cytotoxic agents and argue in favor of the therapeutic potential of these compounds in immune disorders and cancer. Expand
Cannabinoid-receptor expression in human leukocytes.
TLDR
The demonstration of cannabinoid-receptor expression at both mRNA and protein levels on human leukocytes provides a molecular basis for cannabinoid action on these cells. Expand
Effects of delta-9-tetrahydrocannabinol on human immune function and host defense.
TLDR
Alveolar macrophages recovered from the lungs of marijuana smokers are suppressed in their ability to release pro-inflammatory cytokines and nitric oxide, and kill bacteria, and Macrophage function is restored by treatment with interferon-gamma, a type 1 cytokine. Expand
Pharmacology of cannabinoid receptor ligands.
  • R. Pertwee
  • Chemistry, Medicine
  • Current medicinal chemistry
  • 1999
TLDR
This review summarizes current knowledge about the in vitro pharmacological properties of important CB1 and CB2 receptor ligands and pays particular attention to the binding properties of these ligands, to the efficacies of cannabinoid receptor agonists, as determined using cyclic AMP or [35S]GTPgammaS binding assays, and to selected examples of how these pharmacological Properties can be influenced by chemical structure. Expand
Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism.
TLDR
Results indicate that inhibition of the sRBC AFC response by cannabinoids is mediated, at least in part, by inhibition of adenylate cyclase through a pertussis toxin-sensitive Gi-protein coupled cannabinoid receptor, which supports the premise that cAMP is an important mediator of lymphocyte activation. Expand
Δ9 Tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells
TLDR
Results indicate that THC and nonpsychotropic CBD have complex lineage and derivative specific effects on cytokines consistent with previous animal studies, while of potential benefits in some inflammatory/autoimmune diseases may worsen HIV infection, tumorigenesis and allergic inflammation in the lung. Expand
Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation.
TLDR
St stereoselective immune modulation was observed with the synthetic bicyclic cannabinoid (-)-CP-55,940 versus (+) CP-56,667 and with 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl and the (-)-enantiomer demonstrated greater immunoinhibitory potency than the (+)-isomer, as measured by the in vitro sheep red blood cell antibody-forming cell response. Expand
Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations.
TLDR
The results suggest that CB1 and CB2 can be considered as tissue-selective antigens of the central nervous system and immune system, respectively, and cannabinoids may exert specific receptor-mediated actions on the immune system through the CB2 receptor. Expand
Presence and regulation of the endocannabinoid system in human dendritic cells.
TLDR
It is demonstrated for the first time that the endogenous cannabinoid system is present in human dendritic cells and can be regulated by cell activation. Expand
...
1
2
3
4
5
...